70
Participants
Start Date
February 15, 2025
Primary Completion Date
February 15, 2026
Study Completion Date
March 15, 2026
Metoclopramide (Maxolon)
Participants will receive 0.15 mg/kg of metoclopramide administered intravenously. The drug will be diluted in 2 ml of solution prior to administration.
Saline
patients will recive normal saline 0.9% 2ml intravenous
Assiut University
OTHER